SCHEMBL30353603

SCHEMBL30353603

COc1nc(N)nc(-c2ccco2)c1-c1cc(Cl)c2ncnc(C)c2c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 15/20 0.40
▸ ADORA1 P30542 6/20 0.37
▸ PIK3R1 P27986 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ DHFR P00374 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28342683 1.00 ADORA2A (0.40) ADORA2AADORA1PIK3R1PIK3CADHFR
SCHEMBL30353582 0.90 ADORA2A (0.37) ADORA2AADORA1PIK3R1PIK3CADHFR
SCHEMBL28342689 0.90 ADORA2A (0.37) ADORA2AADORA1PIK3R1PIK3CADHFR
SCHEMBL28345401 0.89 ADORA2A (0.43) ADORA2AADORA1PIK3R1PIK3CA
SCHEMBL30353568 0.89 ADORA2A (0.43) ADORA2AADORA1PIK3R1PIK3CA
SCHEMBL30353584 0.89 ADORA2A (0.37) ADORA2AADORA1PIK3R1PIK3CA
SCHEMBL28345454 0.89 ADORA2A (0.37) ADORA2AADORA1PIK3R1PIK3CA
SCHEMBL30353606 0.87 CCNA2 (0.48) ADORA2AADORA1PIK3R1PIK3CAADORA3
SCHEMBL28342638 0.87 CCNA2 (0.48) ADORA2AADORA1PIK3R1PIK3CAADORA3
SCHEMBL30353599 0.84 ADORA2A (0.41) ADORA2AADORA1PIK3R1PIK3CAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110655509-B 2-aminopyrimidine derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-01-24 — — CN disclosed
Send feedback